MedDataX Logo

Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

NCT ID: NCT00971477

Last Updated: 2010-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-08-31

Study Completion Date

2010-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of psoriasis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction.

The investigators' hypotheses include the following:

1. Compared to in-person visits, the online care model will result in similar clinical improvement in psoriasis disease severity.
2. Compared to in-person visits, the online care model will result in similar improvements in quality of life.
3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psoriasis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Teledermatology Telemedicine Psoriasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Teledermatology

Online Telemedicine Group

Group Type EXPERIMENTAL

Online Teledermatology Care

Intervention Type OTHER

Patients randomized to the intervention group will have their scheduled follow-up visits online via a store and forward teledermatology modality.

Usual Care

Conventional in-office care

Group Type ACTIVE_COMPARATOR

Conventional in Office Care

Intervention Type OTHER

Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online Teledermatology Care

Patients randomized to the intervention group will have their scheduled follow-up visits online via a store and forward teledermatology modality.

Intervention Type OTHER

Conventional in Office Care

Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Health care service modality Health care service modality

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older at time of consent, may be men or women.
* Requiring treatment of psoriasis for medically-indicated reasons.
* Capable of giving informed consent.
* Able to have their skin imaged by themselves or by family members.

Exclusion Criteria

* Non-English speaking individuals.
* Individuals lacking access to a digital camera and computer with internet connection.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

UC Davis Department of Dermatology

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

April W Armstrong, MD

Role: PRINCIPAL_INVESTIGATOR

UC Davis Department of Dermatology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UC Davis Department of Dermatology

Sacramento, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009172431

Identifier Type: -

Identifier Source: org_study_id